We demonstrate that both migration (as tested in a scratch assay) and invasion of glioma cells (tested in a Matrigel assay) were  significantly reduced in FOXM1-depleted cells with downregulated ANXA2R expression (Fig. 6M, N). The gene discussed is ANXA2R; the disease is central nervous system cancer.